We first find that the NMT1 number of transcripts is about eight times (23) the number of NMT2 transcripts in all cell lines on average, and second, that there is a heterogenous but significant reduction of NMT2 expression in numerous hematological cancer cell lines in comparison to other types of cancer cell lines (Supplementary Fig. 15A, B). The gene discussed is NMT2; the disease is cancer.